Donor Lymphocyte Infusion and Molecular Monitoring for Relapsed Myelofibrosis After Hematopoietic Cell Transplantation

Hematopoietic cell transplantation (HCT) is a curative approach for myelofibrosis patients, but relapse is a major cause of treatment failure. We investigated the effect of donor lymphocyte infusion (DLI) in 37 patients with molecular (n = 17) or hematological relapse (n = 20) after HCT. Patients re...

Descripción completa

Detalles Bibliográficos
Autores principales: Gagelmann, Nico, Wolschke, Christine, Badbaran, Anita, Janson, Dietlinde, Berger, Carolina, Klyuchnikov, Evgeny, Ayuk, Francis, Fehse, Boris, Kröger, Nicolaus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10317484/
https://www.ncbi.nlm.nih.gov/pubmed/37404772
http://dx.doi.org/10.1097/HS9.0000000000000921

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10317484/
https://www.ncbi.nlm.nih.gov/pubmed/37404772
http://dx.doi.org/10.1097/HS9.0000000000000921

Ejemplares similares